AU2904700A - Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa - Google Patents

Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa

Info

Publication number
AU2904700A
AU2904700A AU29047/00A AU2904700A AU2904700A AU 2904700 A AU2904700 A AU 2904700A AU 29047/00 A AU29047/00 A AU 29047/00A AU 2904700 A AU2904700 A AU 2904700A AU 2904700 A AU2904700 A AU 2904700A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pathological conditions
conditions caused
protozoa
yeasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29047/00A
Inventor
Gunther Bellmann
Gudrun Claus-Herz
Christoph Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Gerhard Mann Chem Pharm Fabrik GmbH
Original Assignee
Dr Gerhard Mann Chem Pharm Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Gerhard Mann Chem Pharm Fabrik GmbH filed Critical Dr Gerhard Mann Chem Pharm Fabrik GmbH
Publication of AU2904700A publication Critical patent/AU2904700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and/or protozoa. The inventive composition is especially provided in the form of an aqueous solution, of a gel capable of dripping, of an ointment or the like. The invention also relates to the use of the pharmaceutical composition in order to produce a medicament for treating the pathological conditions caused by the aforementioned pathogens. The invention additionally relates to the use of the pharmaceutically active substances for producing ophthalmic compositions.
AU29047/00A 1999-04-22 2000-01-13 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa Abandoned AU2904700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19918324A DE19918324A1 (en) 1999-04-22 1999-04-22 Bactericidal, virucidal, fungicidal and antiprotozoal pharmaceutical composition, especially for ophthalmological use, contains benzalkonium salt
DE19918324 1999-04-22
PCT/EP2000/000191 WO2000064429A1 (en) 1999-04-22 2000-01-13 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa

Publications (1)

Publication Number Publication Date
AU2904700A true AU2904700A (en) 2000-11-10

Family

ID=7905524

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29047/00A Abandoned AU2904700A (en) 1999-04-22 2000-01-13 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa

Country Status (8)

Country Link
EP (1) EP1171107B1 (en)
AT (1) ATE284209T1 (en)
AU (1) AU2904700A (en)
DE (2) DE19918324A1 (en)
ES (1) ES2234569T3 (en)
HK (1) HK1043739A1 (en)
PT (1) PT1171107E (en)
WO (1) WO2000064429A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767216B2 (en) 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
CA2604392A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
DE102006010643A1 (en) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Using quaternary ammonium compounds to inhibit precipitation of fluoroquinolone antibiotics, particularly in ready-for-use formulations for veterinary medicine
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
WO2020023666A1 (en) * 2018-07-24 2020-01-30 Orthophor, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU499860B2 (en) * 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
IT1082339B (en) * 1977-02-07 1985-05-21 Zambelletti Dr L Spa COMPOUND WITH DISINFECTANT ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
DE3528209C2 (en) * 1984-08-07 1993-10-28 Fresenius Ag disinfectant
FR2616065A1 (en) * 1987-06-02 1988-12-09 Pabst Jean Yves Quaternary ammonium-based pharmaceutical aerosol
IL87724A (en) * 1987-09-11 1992-01-15 Syntex Inc Ophthalmic compositions,their preparation and use
FR2620698B1 (en) * 1987-09-23 1990-08-10 Atlantic Pharma Prod QUATERNARY AMMONIUM FLUORIDE AND ITS APPLICATION IN AN INHIBITOR OR DESTRUCTIVE SUBSTANCE OF SINGLE-CELL LIVING BEINGS
WO1994015597A1 (en) * 1993-01-11 1994-07-21 Allergan, Inc. Ophthalmic compositions comprising benzyllauryldimethylammonium chloride
FR2715300B1 (en) * 1994-01-24 1996-03-29 Aromafarm Ltd Benzalkonium fluoride solution for injection and application as an antiviral or anti-infective.
JPH0812572A (en) * 1994-07-01 1996-01-16 Kosakai:Kk Therapeutic agent for dermatomycosis
JP3987593B2 (en) * 1995-10-02 2007-10-10 サンスター株式会社 Oral composition containing sodium chloride and magnesium chloride
DE19614823A1 (en) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmic composition with prolonged retention time on the eye
JPH10130156A (en) * 1996-10-30 1998-05-19 Teika Seiyaku Kk Eye drop composition
US5994383A (en) * 1997-11-18 1999-11-30 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using the same
DE19837549A1 (en) * 1998-08-19 2000-02-24 Beiersdorf Ag Use of quaternary nitrogen compounds for treatment and prevention of atopic eczema

Also Published As

Publication number Publication date
EP1171107A1 (en) 2002-01-16
PT1171107E (en) 2005-03-31
HK1043739A1 (en) 2002-09-27
DE19918324A1 (en) 2000-10-26
WO2000064429A1 (en) 2000-11-02
EP1171107B1 (en) 2004-12-08
ES2234569T3 (en) 2005-07-01
DE50008908D1 (en) 2005-01-13
ATE284209T1 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
CA2408142A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA02005173A (en) Remedies for diseases in association with decrease in bone mass.
WO2002009637A3 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
ES2133722T3 (en) USE OF SIMPLE OR CONJUGATED DEXTRANS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO PREVENT OR REDUCE THE RISK OF INFECTION OF BACTERIAL PATHOGENIC GERMS.
AU2904700A (en) Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa
CA2368165A1 (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
AU2002215982A1 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
AU2001261516A1 (en) Semi-solid delivery vehicle and pharmaceutical compositions
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
AU2420001A (en) Methods and compositions for the treatment of pain
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
BR0313589A (en) Use of fermented wheat germ extract as anti-inflammatory agent
AU2003210850A1 (en) N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
WO2002049633A3 (en) Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
HK1050203A1 (en) Novel fusidic acid derivatives.
WO2002070537A3 (en) Fusidic acid derivatives
EP1652525A4 (en) Anti-coronavirus drug
WO2003059297A3 (en) Dermatological topical compositions and a process for the preparation thereof
AU8160094A (en) Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation
MXPA05014081A (en) Benzofuran derivatives and their use in the treatment of microbial infections.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase